Mesoblast (MESO) EBITDA Margin Growth (3y) (2019 - 2023)
Mesoblast (MESO) EBITDA Margin Growth (3y) (2019 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Mesoblast |
21.68 Bn |
21.55 Bn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2023 |
-6.37 Mn |
| Mar 31, 2023 |
-632,500.00 |
| Dec 31, 2022 |
-459,816.00 |
| Sep 30, 2022 |
-17,164.00 |
| Jun 30, 2022 |
8.68 Mn |
| Mar 31, 2022 |
2.24 Mn |
| Dec 31, 2021 |
1.74 Mn |
| Sep 30, 2021 |
1.67 Mn |
| Jun 30, 2021 |
34.84 Mn |
| Mar 31, 2021 |
-124,001.00 |
| Dec 31, 2020 |
2.40 Mn |
| Sep 30, 2020 |
-67,080.00 |
| Jun 30, 2020 |
559,601.00 |
| Dec 31, 2019 |
-3.95 Mn |
| Jun 30, 2019 |
43,206.00 |
